My Treatment Approach: Expert Insights Into the Management of Polycythemia Vera - Episode 13

Future Perspectives in the Treatment of Polycythemia Vera

September 22, 2023

John Mascarenhas, MD, Joe Scandura, MD, PhD

John Mascarenhas, MD, and Joe Scandura, MD, PhD, close their discussion by highlighting what to look forward to in the future of polycythemia vera treatment.

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

Remaining Time 0:00

EP. 1: Risk Assessment in Patients With Polycythemia Vera (PV)

EP. 2: Reducing Risk of Disease Progression in Patients With PV

EP. 3: Typical Presentation of a Patient With PV

EP. 4: Importance of Bone Marrow Biopsy For Diagnosis of PV

EP. 5: Reducing Risk of Thrombosis in Patients With PV

EP. 6: Factoring Symptom Burden Into Treatment Decision-Making for Patients With PV

EP. 7: Managing Toxicities of Hydroxyurea in Patients With PV

EP. 8: Managing Toxicities of Ropeginterferon Alpha-2b in Patients With PV

EP. 9: Key Trials in the Treatment of PV

EP. 10: Treatment Approaches for High-Risk Patients With PV

EP. 11: Influence of Driver Mutations on Response to Ropeginterferon Alpha-2b in Patients with PV

EP. 12: Ruxolitinib in the Treatment of PV

Now Viewing

EP. 13: Future Perspectives in the Treatment of Polycythemia Vera